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Syndecan-3 gets the message
B
espalov et al. catch several 
growth factors that are essen-
tial for brain development be-
ing unfaithful. The researchers show 
that the molecules consort with a sec-
ond receptor.
Glial cell line–derived neurotrophic 
factor (GDNF) and three related growth 
factors make up the GDNF family li-
gands, or GFLs. The molecules are mov-
ers and shapers in the nervous system. 
GFLs nurture neurons, trigger their neurites to grow, and prod the cells 
to migrate as the brain develops. Previous work identifi  ed GFR- as the 
GFL co-receptor. GFR- relays the signal to either of two other mem-
brane receptors, RET or NCAM. However, researchers have found that 
some neurons can respond to GDNF even though they lack RET and 
NCAM, suggesting the GFLs can switch to a different receptor.
Their other partner, Bespalov et al. discovered, is syndecan-3, a 
heparan sulfate proteoglycan. Which receptor GFLs use depends on the 
situation, the team found. Free-fl  oating GFLs hook up with GFR-. But 
the growth factors often build up on the extracellular matrix (ECM), 
boosting their local concentrations. When attached to the ECM, three 
of the four GFLs send messages through syndecan-3.
In the embryo, GABAergic neurons, which are key inhibitory 
cells, travel from their birthplace in the medial ganglionic eminence 
into the brain cortex. To determine whether GFLs spur this behavior 
through syndecan-3, the researchers set beads that exude GDNF atop 
slices of rat brain. GABAergic neurons slithered toward the beads in 
slices from control animals, but not in tissue from animals lacking 
syndecan-3. The interaction between GFLs and syndecan-3 might 
therefore be critical for shaping the developing brain.
Bespalov, M.M., et al. 2011. J. Cell Biol. doi:10.1083/jcb.201009136.
Cancer cells mothball mRNA after microtubule collapse
T
umor cells are often short of 
oxygen. Carbonaro et al. ex-
plain how microtubules (MTs) 
help control production of a protein 
that lets the cells survive.
By switching on more than 100 
genes, the transcription factor HIF-1 
helps cancer cells endure low oxygen 
levels. HIF-1, a component of HIF-1, 
is a promising drug target because more 
than 70% of tumors overproduce it. How 
cells control HIF-1 expression remains 
unclear. The researchers previously dis-
covered that taxol and other drugs that disrupt MT dynamics also re-
duce production of HIF-1. The unanswered question was how MTs 
affect HIF-1 synthesis.
Carbonaro et al. discovered that HIF-1 mRNA attaches to micro-
tubules and scoots along them, presumably traveling to locations where 
it is translated. When this movement stalled after treatment with taxol 
or related drugs, cells stowed HIF-1 mRNA inside cytoplasmic struc-
tures called P-bodies, where abundant microRNAs shut down transla-
tion of HIF-1 mRNA. The researchers found that when they dosed 
cells with the microtubule-disassembling drug nocodazole and then re-
moved it, the HIF-1 mRNA emerged from hiding, and the cells once 
again began manufacturing the protein. The researchers also showed 
that they could thwart taxol’s inhibitory effect on HIF-1 by blocking 
microRNAs and knocking down the P-body protein Argonaute2.
The work indicates that HIF-1 expression depends on the 
state of the microtubule cytoskeleton. Drugs such as taxol that in-
terfere with microtubule dynamics might kill cancer cells by pre-
venting them from making HIF-1 protein. The fi  ndings also raise 
the possibility that translation of HIF-1 mRNA—and possibly 
other mRNAs—occurs on MTs.
Carbonaro, M., et al. 2011. J. Cell Biol. doi:10.1083/jcb.201004145.
Depolymerization of micro-
tubules (magenta) spurred 
this cancer cell to make more 
P-bodies (green), where it 
stores HIF-1 mRNAs.
Receptors flex to remove neurotransmitter brake
K
upchik et al. reveal how shape-shifting synaptic receptors 
help set neurotransmitters free.
Researchers have known for more than 50 years that 
calcium controls neurotransmitter release. When an action potential 
reaches the synapse, calcium rushes into the pre-synaptic neuron, 
prompting it to rapidly unload neurotransmitters. But several lines 
of evidence suggest that calcium gets assistance from G protein–
coupled receptors (GPCRs) at pre-synaptic nerve endings. The re-
ceptors’ best known job in synapses is adjusting the amount of ace-
tylcholine and other neurotransmitters that the neuron discharges. 
Because this task takes seconds or even minutes to perform, how 
GPCRs regulate a process that occurs in milliseconds is unclear. Four 
years ago, the researchers furnished a possible answer, discovering 
that the arrival of the action potential at the synapse spurs “charge 
movements” in GPCRs. Charged amino acids in the proteins change 
position, altering the receptors’ shape.
To determine whether these molecular twitches help unleash 
neurotransmitters, the researchers used the compound carbachol to 
inhibit charge movements in the M2R receptor, which governs the 
release of acetylcholine. Kupchik et al. could apply carbachol at pre-
cise times with a fl  ash of UV light, which liberates a caged version of 
the molecule. The team found that blocking charge movements just 
before or during the action potential cut neurotransmitter release. But 
adding the inhibitor just afterward had no effect.
The researchers suggest GPCRs serve as a brake that prevents 
neurotransmitter vesicles from merging with the presynaptic membrane. 
When an action potential reaches the synapse, the receptors change 
shape, removing this inhibition. Thus, GPCR charge movements dictate 
the timing of neurotransmitter release, whereas calcium spurs exocyto-
sis. The researchers now want to determine whether the same mecha-
nism works for other neurotransmitters, such as glutamate.
Kupchik, Y.M., et al. 2011. J. Cell Biol. doi:10.1083/jcb.201007053.
Immobilized GDNF spurs 
neurites to elongate in 
these hippocampal cells.